Official Journal of the Human Genome Organisation
From: Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer
BRCA mutations‡ | ||||||||
---|---|---|---|---|---|---|---|---|
Carriers (N = 28) * | Non-Carriers (N = 239) * | Unadjusted | ||||||
n | Col % | n | Col % | χ2 | P-value | OR† | 95% CI | |
LVI (Lymphatic invasion): | ||||||||
Absent/suspiciousa | 20 | 90.9 | 107 | 64.5 | 1.00** | |||
Present | 2 | 9.9 | 59 | 35.5 | 6.20 | 0.01 | 0.18 | (0.04, 0.80) |
Grade: | ||||||||
1 and 2 | 9 | 37.5 | 103 | 60.6 | 1.00** | |||
3 | 15 | 62.5 | 67 | 39.4 | 4.59 | 0.03 | 2.56 | (1.06, 6.19) |
Type: | ||||||||
DCIS (Ductal carcinoma In Situ) | 8 | 23.5 | 33 | 15.2 | 1.00** | |||
Invasive | 26 | 76.5 | 84 | 84.8 | 1.49 | 0.22 | 0.58 | (0.24, 1.40) |
Stage: | ||||||||
Stage 0 | 8 | 25.8 | 32 | 15.7 | ||||
Stage 1 | 10 | 32.3 | 56 | 27.5 | 1.00** | |||
Stage 2, 3, and 4 | 13 | 41.9 | 116 | 56.9 | 1.80 | 0.30 | 0.63 | (0.26, 1.52) |
T stage (Tumor size): | ||||||||
T0 | 8 | 24.2 | 30 | 14.6 | ||||
T1 | 16 | 48.5 | 74 | 36.1 | 1.00** | |||
T2, 3 and 4 | 9 | 27.3 | 84 | 41.0 | 6.50 | 0.05 | 0.41 | (0.17, 0.98) |
N stage (Lymph node involvement): | ||||||||
N0 | 22 | 75.9 | 130 | 64.0 | 1.00** | |||
N1, 2, and 3 | 7 | 24.1 | 73 | 36.0 | 1.57 | 0.21 | 0.57 | (0.23, 1.39) |
M stage (Metastatic): | ||||||||
M0 | 32 | 100.0 | 201 | 95.7 | ||||
M1 | 0 | 0 | 9 | 4.3 | 1.42 | 0.23 | – | – |
ER (Estrogen receptor): | ||||||||
Positive | 15 | 48.4 | 141 | 72.3 | 1.00** | |||
Negative | 16 | 51.6 | 54 | 27.7 | 7.16 | 0.007 | 2.78 | (1.28, 5.88) |
PR (Progesterone receptor): | ||||||||
Positive | 11 | 36.7 | 112 | 58.6 | 1.00** | |||
Negative | 19 | 63.3 | 79 | 41.4 | 5.07 | 0.02 | 2.44 | (1.10, 5.56) |
Cerb 2 (Protein of HER2 Oncogene): | ||||||||
Positive | 9 | 31.0 | 87 | 49.2 | 1.00** | |||
Negative | 20 | 69.0 | 90 | 50.8 | 3.29 | 0.07 | 2.13 | (0.93,5.00) |
Triple negative (ER−/PR−/Cerb2−): | ||||||||
No | 15 | 51.7 | 131 | 74.4 | 1.00** | |||
Yes | 14 | 48.3 | 45 | 25.6 | 6.26 | 0.01 | 2.11 | (1.22, 5.88) |
Ki67 index (% of growing cells): | ||||||||
<12% | 6 | 60.0 | 28 | 50.9 | 1.00** | |||
>12% | 4 | 40.0 | 27 | 49.1 | 0.28 | 0.60 | 0.69 | (0.18,2.70) |